Venture Catalysts, as one of the top-ranked integrated incubators and early-stage investment platforms, has officially declared a successful and comprehensive exit of Pee Safe. The change comes after a major financial breakthrough of the hygiene and wellness brand, which has recently raised a massive $32 million funding round spearheaded by the global healthcare-oriented private equity company, OrbiMed.

The event is a significant liquidity event to the early-stage investment market, as it shows that the Indian startup ecosystem can create significant value when strategic capital is combined with scaled business models.

Early investment and focused proposition

The secondary element of the latest $32 million round of investment enabled the exit. This particular structure enabled a few early investors, such as Venture Catalysts, to attain liquidity through the conversion of long-term value into cash returns.

In the case of Venture Catalysts and its limited partners, the timescale of this exit in January 2026 will be a culmination of a multi-year process in which the brand has transformed into a powerhouse in the personal hygiene and wellness industry, which was initially a niche startup. This investment is successful, a fact that testifies to the efficiency of the secondary market in offering exits to those who have previously backed the project and introducing larger institutional actors to the next stage of development.

Venture Catalysts and Pee Safe have a history dating back to August 2017, the year when the investment platform first supported the company. Pee Safe was then at an early inflexion point that was critical because it had started with a narrow-scoped proposition that specifically targeted toilet hygiene.

In June 2017, venture Catalysts was engaged in a pre-Series round, which helped the company to broaden its vision. This was an initial step towards enabling the brand to transcend the original scope to create a significantly more robust portfolio that includes personal hygiene and general wellness products that are structured to suit a wide range of consumers.

Venture Catalysts not only offered capital but also recognized the potential of the brand in its early years. The support provided to the company during this timeframe was instrumental in assisting the company to overcome the intricacies of the consumer market and thus enabled it to change its image from a single product enterprise to a hybrid hygiene brand. This strategic vision has now been proven by the fact that the brand is drawing the interest of the highest level of global private equity, including that of OrbiMed, which focuses on the sphere of healthcare and wellness.

Financial returns and market presence

Pee Safe has shown impressive business and operational stability and expansions throughout the years, implementing a strong omnichannel business model that guarantees expansive access. The products of the brand are sold through an extensive range of over 50,000 offline retail touchpoints spread across more than 100 cities in India. It has a robust physical presence that is enhanced by a robust online strategy, where the products of the company are displayed on the most important e-commerce and quick commerce platforms, as well as direct-to-consumer stores operated by the company.

This diversified distribution strategy has played an important role in ensuring that the brand has been able to sustain a steady growth rate. The financial reports and releases show that Pee Safe has been experiencing a consistent growth profile with an average growth rate of about 45 to 50% per annum in the past two fiscal years.

Such a regular performance in a competitive market implies a high level of consumer demand for wellness and hygiene products and a high level of effective implementation plan by the management team. The scaling factor and the preservation of high growth rates also made the company a good target of secondary exit, which awarded Venture Catalysts with its awesome payoffs.

Of particular interest to the venture capital sector is the financial details of the exit. When the transaction was consummated in January 2026, Venture Catalysts indicated that the exit produced a 9.6x on invested capital. The investment yielded a XIRR of 30.53%, which represented the fund and the limited partners.

Such statistics highlight the fact that early-stage investing has high-yield potential when it is focused on strong businesses with a clear liquidity route. This exit is a validation of the platform of being able to isolate and develop high-potential startups that would later graduate to institutional funding rounds.

Venture Catalysts has indicated that it will continue to be a loyal partner to the entrepreneurs in the consumer, healthcare, and technology fields. The company’s strategy has remained to discover scalable businesses with strong fundamentals and an effective roadmap towards providing liquidity to investors.

With its ecosystem support and strategic capital, Venture Catalysts plans to keep on accelerating long-term value creation in the startup environment. The sale of Pee Safe is used as a yardstick for the firm, as it shows the effective implementation of the investment philosophy of the firm, starting at the seed level up to the profitable institutional exit.

Conclusion

The complete withdrawal of Venture Catalysts into Pee Safe is a solid success story of the Indian early-stage investment industry. The 9.6x returns and 30.53% XIRR have shown that the platform can offer significant returns to those investors who support innovative brands at their initial inflection points.

The fact that the brand was acquired by a global company such as OrbiMed is an indication that Pee Safe is at a stage of maturity and size that makes it one of the highest-ranking Indian consumer wellness firms. With the brand in the middle of its ongoing omnichannel development and steady rise, the financing granted to the first investors, such as Venture Catalysts, is likely to drive additional investments to the next generation of prospective Indian startups.